384835-91-0

Upstream product

• 6994-25-8 3-amino-4-pyrazolecarboxylic acid ethyl ester 
• 824-94-2 p-methoxybenzyl chloride 

Downstream Products

• 1235314-17-6 ethyl 3-(dimethylamino)-1-(4-methoxybenzyl)-1H-pyrazole-4-carboxylate 
• 1267635-23-3 C₂₅H₂₁ClN₄O₂ 
• 1267635-22-2 C₁₉H₁₇ClN₄O₂ 
• 1267635-20-0 C₂₁H₂₁ClN₄O₅ 
• 1267635-18-6 C₁₅H₁₉N₃O₃ 
• 1267635-16-4 C₁₇H₁₈F₃N₃O₄ 
• 1267635-14-2 C₁₆H₁₆F₃N₃O₄ 
• 1355994-31-8 3-amino-N-methoxy-1-(4-methoxybenzyl)-N-methyl-1H-pyrazole-4-carboxamide 
• 1355994-27-2 ethyl 1-(4-methoxybenzyl)-3-((1-methyl-1H-pyrazol-3-yl)methylamino)-1H-pyrazole-4-carboxylate 

Relevant academic research and scientific papers

NOVEL TETRAHYDROPYRAZOLO[3,4-B]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention relates to novel compounds of Formula (I), wherein M, A and Y are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors - subtype 4 ("mGluR4") which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.

NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

The present invention relates to novel compounds of Formula (I), wherein M, P, A and (B)n are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors - subtype 4 ( mGluR4 ) which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.